Objective This article aims to analyse the rate of antiphospholipid antibodies (aPL)
negativisation in patients with antiphospholipid syndrome (APS), and to evaluate potential …

Introduction: Some patients with positive antiphospholipid antibodies (aPL) have not been
included in randomized clinical trials or observational registries and, therefore, information …

See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary
Background: The characteristics and the clinical course of antiphospholipid syndrome (APS) …

This issue of Seminars in Thrombosis & Hemostasis is devoted to antiphospholipid (aPL)
antibodies and the antiphospholipid syndrome (APS). aPL antibodies are well-recognized …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by clinical
symptoms of vascular thrombosis and/or pregnancy morbidity in the presence of …

Background: The antiphospholipid syndrome (APS) is an autoimmune condition
characterised by vascular thromboses and/or pregnancy morbidity. Diagnosis of APS …

Antiphospholipid syndrome (APS) is an acquired autoimmune disease defined by the
presence of persistently positive antiphospholipid antibodies (aPLs) on two or more …

Objective To evaluate the clinical outcome after aPL (antiphospholipid antibodies)
disappearance in primary APS patients. Methods From a cohort of 70 patients with primary …

Recommended treatment for patients with primary antiphospholipid syndrome (APS) after a
thrombotic event is long-term anticoagulation. Few patients with APS and previously positive …

Introduction The antiphospholipid syndrome (APS) is an acquired immune disorder defined
by the presence of thrombosis (arterial and/or venous) and/or pregnancy morbidity along …